92 related articles for article (PubMed ID: 3099097)
1. The c-abl, bcr and C lambda genes are amplified in a cell line but not in the uncultured cells from a patient with chronic myelogenous leukemia.
Blick MB; Andersson BS; Gutterman JU; Keating A; Beran M
Leuk Res; 1986; 10(12):1401-9. PubMed ID: 3099097
[TBL] [Abstract][Full Text] [Related]
2. Chronic myelogenous leukemia: amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis.
Collins SJ; Groudine MT
Blood; 1987 Mar; 69(3):893-8. PubMed ID: 3545323
[TBL] [Abstract][Full Text] [Related]
3. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.
Clark SS; McLaughlin J; Crist WM; Champlin R; Witte ON
Science; 1987 Jan; 235(4784):85-8. PubMed ID: 3541203
[TBL] [Abstract][Full Text] [Related]
4. Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.
Collins SJ
J Clin Invest; 1986 Nov; 78(5):1392-6. PubMed ID: 3021820
[TBL] [Abstract][Full Text] [Related]
5. Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562.
Collins SJ; Groudine MT
Proc Natl Acad Sci U S A; 1983 Aug; 80(15):4813-7. PubMed ID: 6308652
[TBL] [Abstract][Full Text] [Related]
6. Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.
Konopka JB; Clark S; McLaughlin J; Nitta M; Kato Y; Strife A; Clarkson B; Witte ON
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4049-52. PubMed ID: 3012546
[TBL] [Abstract][Full Text] [Related]
7. Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome.
Stam K; Heisterkamp N; Grosveld G; de Klein A; Verma RS; Coleman M; Dosik H; Groffen J
N Engl J Med; 1985 Dec; 313(23):1429-33. PubMed ID: 3864009
[TBL] [Abstract][Full Text] [Related]
8. C-sis and C-abl expression in chronic myelogenous leukemia and other hematologic malignancies.
Romero P; Blick M; Talpaz M; Murphy E; Hester J; Gutterman J
Blood; 1986 Mar; 67(3):839-41. PubMed ID: 3456250
[TBL] [Abstract][Full Text] [Related]
9. Additional c-abl/bcr rearrangements in a CML patient exhibiting two ph1 chromosomes during blast crisis.
Bartram CR; de Klein A; Hagemeijer A; Carbonell F; Kleihauer E; Grosveld G
Leuk Res; 1986; 10(2):221-5. PubMed ID: 3005778
[TBL] [Abstract][Full Text] [Related]
10. Mapping of four distinct BCR-related loci to chromosome region 22q11: order of BCR loci relative to chronic myelogenous leukemia and acute lymphoblastic leukemia breakpoints.
Croce CM; Huebner K; Isobe M; Fainstain E; Lifshitz B; Shtivelman E; Canaani E
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7174-8. PubMed ID: 3118359
[TBL] [Abstract][Full Text] [Related]
11. Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.
Rosson D; Reddy EP
Mutat Res; 1988 May; 195(3):231-43. PubMed ID: 3129652
[TBL] [Abstract][Full Text] [Related]
12. Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL).
Clark SS; McLaughlin J; Timmons M; Pendergast AM; Ben-Neriah Y; Dow LW; Crist W; Rovera G; Smith SD; Witte ON
Science; 1988 Feb; 239(4841 Pt 1):775-7. PubMed ID: 3422516
[TBL] [Abstract][Full Text] [Related]
13. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
[TBL] [Abstract][Full Text] [Related]
14. Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell line.
Eisbruch A; Blick M; Evinger-Hodges MJ; Beran M; Andersson B; Gutterman JU; Kurzrock R
Cancer; 1988 Sep; 62(6):1171-8. PubMed ID: 3044574
[TBL] [Abstract][Full Text] [Related]
15. Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration.
Konopka JB; Watanabe SM; Singer JW; Collins SJ; Witte ON
Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1810-4. PubMed ID: 3856862
[TBL] [Abstract][Full Text] [Related]
16. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
[TBL] [Abstract][Full Text] [Related]
17. KBM-7, a human myeloid leukemia cell line with double Philadelphia chromosomes lacking normal c-ABL and BCR transcripts.
Andersson BS; Collins VP; Kurzrock R; Larkin DW; Childs C; Ost A; Cork A; Trujillo JM; Freireich EJ; Siciliano MJ
Leukemia; 1995 Dec; 9(12):2100-8. PubMed ID: 8609723
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in expression of the bcr-abl fusion transcript in CML blast crisis.
Andrews DF; Collins SJ
Leukemia; 1987 Oct; 1(10):718-24. PubMed ID: 3312834
[TBL] [Abstract][Full Text] [Related]
19. Expression of a translocated c-abl gene in hybrids of mouse fibroblasts and chronic myelogenous leukaemia cells.
Kozbor D; Giallongo A; Sierzega ME; Konopka JB; Witte ON; Showe LC; Croce CM
Nature; 1986 Jan 23-29; 319(6051):331-3. PubMed ID: 3455750
[TBL] [Abstract][Full Text] [Related]
20. Absence of the hybrid bcr-abl mRNA in Ph1-positive B lymphoblastoid cell lines established from a patient with chronic myelogenous leukemia.
Yamada T; Oikawa T; Kuzumaki N; Takagi N; Sasaki M
Int J Cancer; 1987 Dec; 40(6):778-83. PubMed ID: 3121521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
